The CD2 and CD28 adhesion molecules induce long‐term autocrine proliferation of CD4+ T cells
- 1 March 1993
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 23 (3) , 608-613
- https://doi.org/10.1002/eji.1830230304
Abstract
In vitro human T lymphocyte activation requires two‐signal triggering delivered by lectins, phorbol esters or antibodies directed against surface molecules. Stimulation of adhesion molecules by CD2 and/or CD28 antibodies defines alternative activation pathways. Activation by CD2 + CD28 monoclonal antibodies induces high‐level, long‐lasting and monocyte‐independent proliferation of highly purified T cells. Limiting dilution cultures showed that CD28 in association with CD2 or CD3, without addition of exogenous cytokines, induced single‐cell proliferation. CD2 + CD28 stimulation induced long‐term interleukin (IL)‐2‐dependent autocrine proliferation of CD4+ T cell clones. We tried to elucidate this long‐term proliferation by evaluating cytokine secretion and cytokine dependency. CD28 associated to CD3 or CD2 induced high levels of IL‐2, tumor necrosis factor (TNF) and IL‐4 secretion for 10 days, in contrast to CD3 alone which induced only TNF secretion. Cytokines of the monocytic lineage were also secreted, such as colony‐stimulating factor‐1, granulocyte macrophage colony‐stimulating factor or IL‐1, the latter being more specific of CD2 + CD28 activation. Blocking antibodies confirmed the crucial role of IL‐2 in CD2 + CD28 activation. Anti‐IL‐4, anti‐IL‐7 receptor or anti‐TNF antibodies had no effect on proliferation. Stimulation with CD2 + CD28 induced long‐term autocrine (at least for IL‐2) proliferation for CD4+ T cells, with no evidence for the implication of another cytokine among those tested other than IL‐2. This represents a model for long‐term autocrine growth for non‐leukemic cells.Keywords
This publication has 27 references indexed in Scilit:
- Regulation of lymphokine expression in T cell activation. I. Rapid loss of interleukin‐specific RNA after removal of the stimulating signalEuropean Journal of Immunology, 1991
- Mouse LFA‐3 studied with chimeric soluble CD2 shows preferential expression on lymphoid cellsEuropean Journal of Immunology, 1991
- Activated but not resting T cells or thymocytes express colony‐stimulating factor 1 mRNA without co‐expressing c‐fms mRNAEuropean Journal of Immunology, 1990
- Clonal analysis of functionally distinct human CD4+ T cell subsets.The Journal of Experimental Medicine, 1988
- Polypeptides on human B lymphocytes associated with cell activationHuman Immunology, 1986
- Anti‐CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation I. Pairs of anti‐T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12‐O‐tetradecanoylphorbol 13‐acetateEuropean Journal of Immunology, 1986
- An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor proteinCell, 1984
- Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.The Journal of Experimental Medicine, 1983
- Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.The Journal of Experimental Medicine, 1983
- Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. "Modulation" of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytesThe Journal of Experimental Medicine, 1982